Yes. This formula contains prescription hormonal actives including estradiol, progesterone, and liothyronine. A valid prescription from a licensed provider is required after medical evaluation. This formula is for use in women only.

Estradiol and progesterone: mild scalp irritation is most common. Rare systemic effects including breast tenderness, fluid retention, or mood changes may occur with significant absorption. Liothyronine: palpitations, tachycardia, or anxiety are possible if significant systemic absorption occurs, particularly in thyroid-sensitive patients. Azelaic acid: mild scalp tingling, warmth, or dryness in the first one to two weeks. Transient increased shedding in weeks 4-8 as follicles re-enter anagen is expected and temporary.

Pregnant women and those planning pregnancy should not use this formula. Not appropriate for men or children. Patients with estrogen receptor-positive breast cancer, endometrial cancer, or other hormone-sensitive malignancies require oncologist evaluation. Patients with hyperthyroidism, thyrotoxicosis, or significant cardiovascular arrhythmia must not use without specialist clearance due to the liothyronine component.

Patients on systemic HRT (oral or transdermal estradiol, progesterone) require coordinated provider management. Patients on any systemic thyroid medication (levothyroxine, desiccated thyroid, or liothyronine) require thyroid function monitoring and potential dose adjustment. Antithyroid medications (methimazole, propylthiouracil) may be partially counteracted. Beta-blockers and cardiovascular medications warrant disclosure due to the thyroid component.

Patients with thyroid disease, cardiovascular conditions, hormone-sensitive malignancy history, undiagnosed uterine bleeding, or liver impairment require individualized provider evaluation before starting. Lab monitoring including thyroid function and hormonal levels is recommended during treatment.